Risedronate reduces vertebral fractures in postmenopausal women with osteoporosis

被引:0
|
作者
Jackson, R
Bensen, W
Ettinger, M
Eastell, R
机构
[1] Reg Osteoporosis Ctr, Stuart, FL USA
[2] Univ Sheffield, Sheffield, S Yorkshire, England
关键词
D O I
暂无
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
P297
引用
收藏
页码:S85 / S85
页数:1
相关论文
共 50 条
  • [1] Risedronate Rapidly Reduces the Risk for Nonvertebral Fractures in Women with Postmenopausal Osteoporosis
    J. T. Harrington
    L. -G. Ste-Marie
    M. L. Brandi
    R. Civitelli
    P. Fardellone
    A. Grauer
    I. Barton
    S. Boonen
    [J]. Calcified Tissue International, 2004, 74 : 129 - 135
  • [2] Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosis
    Harrington, JT
    Ste-Marie, LG
    Brandi, ML
    Civitelli, R
    Fardellone, P
    Grauer, A
    Barton, I
    Boonen, S
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2004, 74 (02) : 129 - 135
  • [3] Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis
    J.-Y. Reginster
    H. W. Minne
    O. H. Sorensen
    M. Hooper
    C. Roux
    M. L. Brandi
    B. Lund
    D. Ethgen
    S. Pack
    I. Roumagnac
    R. Eastell
    [J]. Osteoporosis International, 2000, 11 : 83 - 91
  • [4] Risedronate rapidly reduces vertebral fracture risk in postmenopausal women with established osteoporosis
    Roux, C
    Miller, P
    Gennari, C
    Keller, M
    Sorensen, O
    Ritter-Hrncirik, C
    Barton, I
    Watts, N
    [J]. ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S287 - S287
  • [5] Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis
    Reginster, JY
    Minne, HW
    Sorensen, OH
    Hooper, M
    Roux, C
    Brandi, ML
    Lund, B
    Ethgen, D
    Pack, S
    Roumagnac, I
    Eastell, R
    [J]. OSTEOPOROSIS INTERNATIONAL, 2000, 11 (01) : 83 - 91
  • [6] Risedronate reduces vertebral fractures in men with osteoporosis.
    Ringe, JD
    Dorst, A
    Faber, H
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S160 - S160
  • [7] Risedronate reduces the risk of clinical vertebral fractures as early as 6 months and non-vertebral fractures as early as 12 months in women with postmenopausal osteoporosis.
    Bolognese, M
    Chesnut, C
    Adami, S
    Barton, I
    Watts, N
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S254 - S254
  • [8] Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis - A randomized controlled trial
    Harris, ST
    Watts, NB
    Genant, HK
    McKeever, CD
    Hangartner, T
    Keller, M
    Chesnut, CH
    Brown, J
    Eriksen, EF
    Hoseyni, MS
    Axelrod, DW
    Miller, PD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (14): : 1344 - 1352
  • [9] Strontium ranelate reduces the risk of non vertebral fractures in women with postmenopausal osteoporosis
    Reginster, JY
    Lorenc, RS
    Spector, TD
    Benhamou, C
    Isaia, G
    Brixen, K
    Stucki, G
    Prins, J
    Walravens, M
    Cannata, JB
    De Chatel, R
    Meunier, PJ
    [J]. OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S51 - S52
  • [10] Risedronate reduces the risk of new vertebral fractures in 1 year in postmenopausal women on corticosteroid therapy
    Devogelaer, JP
    Hosking, D
    Wallach, S
    Valent, DJ
    [J]. BONE, 2001, 28 (05) : S228 - S228